Levine MN - Search Results

1

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Schulman S, Beyth RJ, Kearon C, Levine MN. Schulman S, et al. Among authors: levine mn. Chest. 2008 Jun;133(6 Suppl):257S-298S. doi: 10.1378/chest.08-0674. Chest. 2008. PMID: 18574268

2

Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Levine MN, et al. Chest. 2004 Sep;126(3 Suppl):287S-310S. doi: 10.1378/chest.126.3_suppl.287S. Chest. 2004. PMID: 15383476 Review.

3

Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.

Schulman S, Parpia S, Stewart C, Rudd-Scott L, Julian JA, Levine M. Schulman S, et al. Ann Intern Med. 2011 Nov 15;155(10):653-9, W201-3. doi: 10.7326/0003-4819-155-10-201111150-00003. Ann Intern Med. 2011. PMID: 22084331 Free article. Clinical Trial.

4

Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.

Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, Gu CS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, Razdan R, VanderWoude E, Marques V, Kearon C; ATTRACT Trial Investigators. Vedantham S, et al. N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066. N Engl J Med. 2017. PMID: 29211671 Free PMC article. Clinical Trial.

5

Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times.

Anand SS, Bates S, Ginsberg JS, Levine M, Buller H, Prins M, Haley S, Kearon C, Hirsh J, Gent M. Anand SS, et al. Arch Intern Med. 1999 Sep 27;159(17):2029-32. doi: 10.1001/archinte.159.17.2029. Arch Intern Med. 1999. PMID: 10510988

6

Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study.

Douketis JD, Ginsberg JS, Haley S, Julian J, Dwyer M, Levine M, Eisenberg PR, Smart R, Tsui W, White RH, Morris TA, Kaatz S, Comp PC, Crowther MA, Kearon C, Kassis J, Bates SM, Schulman S, Desjardins L, Taillefer R, Begelman SM, Gerometta M. Douketis JD, et al. Thromb Res. 2012 Sep;130(3):381-9. doi: 10.1016/j.thromres.2012.05.011. Epub 2012 Jun 1. Thromb Res. 2012. PMID: 22658414 Clinical Trial.

7

Thrombotic disorders: diagnosis and treatment.

Schafer AI, Levine MN, Konkle BA, Kearon C. Schafer AI, et al. Among authors: levine mn. Hematology Am Soc Hematol Educ Program. 2003:520-39. doi: 10.1182/asheducation-2003.1.520. Hematology Am Soc Hematol Educ Program. 2003. PMID: 14633797 Review.

8

Treatment of venous thromboembolism in cancer patients.

Levine M, Rickles FR. Levine M, et al. Haemostasis. 1998;28 Suppl 3:66-70. doi: 10.1159/000022407. Haemostasis. 1998. PMID: 10069764 Review.

9

Treatment of thrombotic disorders in cancer patients.

Levine M. Levine M. Haemostasis. 1997;27 Suppl 1:38-43. doi: 10.1159/000217481. Haemostasis. 1997. PMID: 9439757 Review.

10

Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer.

Levine MN. Levine MN. Cancer Treat Rev. 2002 Jun;28(3):145-9. doi: 10.1016/s0305-7372(02)00042-7. Cancer Treat Rev. 2002. PMID: 12234566 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page